Hemab Therapeutics Reports Q2 2026 Financial Results

What Happened
Hemab Therapeutics Holdings, Inc. announced its financial results for the quarter ended June 30, 2026 via a press release issued on August 11, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8‑K under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Press release date: August 11, 2026.
• Reporting period: quarter ended June 30, 2026 (Q2 2026).
• The press release is furnished with the Form 8‑K as Exhibit 99.1 and the filing notes the furnished materials are not being “filed” for purposes of Section 18 of the Exchange Act.
• The filing includes an Inline XBRL cover page (Exhibit 104).

Why It Matters
This filing signals that Hemab has released its quarterly earnings and related financial information (revenue, results, and other operational metrics) for Q2 2026. Retail investors should read the furnished press release for the specific earnings figures, revenue and expense details, and any commentary on business trends or guidance that could affect the stock. The Form 8‑K itself is a formal notice that those results are available.